Core Laboratories Inc. /DE/ Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Core Laboratories Inc. /DE/ quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2022 to Q4 2023.
  • Core Laboratories Inc. /DE/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending December 31, 2023 was $71.7M, a 7.42% decline year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $71.7M -$5.75M -7.42% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $77.5M Dec 31, 2022 10-K 2024-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.